.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Daiichi Sankyo
Chubb
Argus Health
US Army
Citi
Fish and Richardson
Federal Trade Commission
Covington
AstraZeneca

Generated: June 26, 2017

DrugPatentWatch Database Preview

Dobutamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dobutamine hydrochloride and what is the scope of dobutamine hydrochloride freedom to operate?

Dobutamine hydrochloride
is the generic ingredient in four branded drugs marketed by Hospira, Teva Parenteral, Watson Labs, Lilly, Luitpold, Baxter Hlthcare, West-ward Pharms Int, Watson Labs Inc, and Teligent Pharma Inc, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for dobutamine hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: dobutamine hydrochloride

Tradenames:4
Patents:1
Applicants:9
NDAs:15
Drug Master File Entries: see list14
Suppliers / Packagers: see list4
Bulk Api Vendors: see list49
Clinical Trials: see list2,315
Patent Applications: see list822
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dobutamine hydrochloride at DailyMed

Pharmacology for Ingredient: dobutamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent Pharma Inc
DOBUTAMINE HYDROCHLORIDE
dobutamine hydrochloride
INJECTABLE;INJECTION074098-001Feb 21, 1995DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
INJECTABLE;INJECTION020255-003Oct 19, 1993APRXYesYes► Subscribe► Subscribe
Hospira
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
INJECTABLE;INJECTION020201-001Oct 19, 1993APRXYesYes► Subscribe► Subscribe
Hospira
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
INJECTABLE;INJECTION020201-003Oct 19, 1993APRXYesYes► Subscribe► Subscribe
Baxter Hlthcare
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
INJECTABLE;INJECTION020255-001Oct 19, 1993APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dobutamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly
DOBUTREX
dobutamine hydrochloride
INJECTABLE;INJECTION017820-002Approved Prior to Jan 1, 19823,987,200► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Merck
Daiichi Sankyo
Fish and Richardson
Deloitte
US Department of Justice
Boehringer Ingelheim
Baxter
Covington
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot